Biliary atresia with splenic malformation syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:244283Q44.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Biliary atresia with splenic malformation syndrome (BASM), also known as biliary atresia splenic malformation syndrome or the syndromic form of biliary atresia, is a rare congenital condition that combines biliary atresia — a progressive obliterative cholangiopathy affecting the bile ducts — with laterality defects and splenic abnormalities. Unlike isolated (non-syndromic) biliary atresia, BASM is present from birth and is thought to arise from disrupted embryonic development of laterality during early gestation. The condition primarily affects the hepatobiliary system and the spleen, but may also involve the cardiovascular system and abdominal organ positioning. Key clinical features include neonatal jaundice (due to obstructed bile flow), acholic (pale) stools, dark urine, and hepatomegaly. Splenic malformations may include polysplenia (multiple small spleens), asplenia (absent spleen), or a double spleen. Associated anomalies can include situs inversus or situs ambiguus (abnormal positioning of abdominal and thoracic organs), preduodenal portal vein, interrupted inferior vena cava, cardiac defects (such as atrial or ventricular septal defects), and intestinal malrotation. The hepatobiliary obstruction leads to progressive liver damage, fibrosis, and eventually biliary cirrhosis if untreated. The primary surgical treatment is the Kasai portoenterostomy (hepatoportoenterostomy), which aims to restore bile flow by connecting the liver directly to the small intestine. However, outcomes of the Kasai procedure in BASM patients tend to be less favorable compared to those with isolated biliary atresia, with a higher rate of failure to clear jaundice. Liver transplantation remains the definitive treatment for patients who develop end-stage liver disease. Early diagnosis and referral to a specialized pediatric hepatobiliary center are critical for optimizing outcomes. The presence of associated cardiac and vascular anomalies may complicate surgical management and requires careful preoperative evaluation.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Biliary atresia with splenic malformation syndrome.

View clinical trials →

No actively recruiting trials found for Biliary atresia with splenic malformation syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Biliary atresia with splenic malformation syndrome community →

No specialists are currently listed for Biliary atresia with splenic malformation syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Biliary atresia with splenic malformation syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Biliary atresia with splenic malformation syndromeForum →

No community posts yet. Be the first to share your experience with Biliary atresia with splenic malformation syndrome.

Start the conversation →

Latest news about Biliary atresia with splenic malformation syndrome

No recent news articles for Biliary atresia with splenic malformation syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Biliary atresia with splenic malformation syndrome

What is Biliary atresia with splenic malformation syndrome?

Biliary atresia with splenic malformation syndrome (BASM), also known as biliary atresia splenic malformation syndrome or the syndromic form of biliary atresia, is a rare congenital condition that combines biliary atresia — a progressive obliterative cholangiopathy affecting the bile ducts — with laterality defects and splenic abnormalities. Unlike isolated (non-syndromic) biliary atresia, BASM is present from birth and is thought to arise from disrupted embryonic development of laterality during early gestation. The condition primarily affects the hepatobiliary system and the spleen, but may

How is Biliary atresia with splenic malformation syndrome inherited?

Biliary atresia with splenic malformation syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Biliary atresia with splenic malformation syndrome typically begin?

Typical onset of Biliary atresia with splenic malformation syndrome is neonatal. Age of onset can vary across affected individuals.